Anagnostics Bioanalysis Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 2
  • Latest Deal Type
  • M&A

Anagnostics Bioanalysis General Information


Developer of systems and tests for multiplex clinical and medical research diagnostics. The company's Hybcell technology aims at providing services in the fields of drugs of abuse screening, severe infections and diagnostics in the field of oncology.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Drug Delivery
Cube Dx
Primary Office
  • Westbahnstrasse 55
  • Saint Valentin, 4300
  • Austria
+43 07435 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Anagnostics Bioanalysis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 00.000 Completed Startup
2. Early Stage VC 27-Feb-2009 00.000 00.000 Completed Startup
1. Accelerator/Incubator 01-Jan-2003 Completed Startup
To view Anagnostics Bioanalysis’s complete valuation and funding history, request access »

Anagnostics Bioanalysis Executive Team (2)

Name Title Board Seat Contact Info
Christoph Reschreiter Chief Executive Officer & Co-Founder
Bernhard Ronacher Chief Scientific Officer & Co-Founder
To view Anagnostics Bioanalysis’s complete executive team members history, request access »

Anagnostics Bioanalysis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anagnostics Bioanalysis Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
PP Capital Venture Capital Minority 000 0000 000000 0
Tecnet Equity Venture Capital Minority 000 0000 000000 0
tech2b Accelerator/Incubator 000 0000 000000 0
To view Anagnostics Bioanalysis’s complete investors history, request access »